FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tobias Klatte

Research Profile

Disorders

Procedures

Nephrectomy

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Michela de Martino; Andrea Haitel; Tobias Klatte; Georg Schatzl; Fritz Wrba; Matthias Waldert
High-risk human papilloma virus infection of the foreskin in asymptomatic boys.
Tobias Klatte; Nils Kroeger; Joshua E Logan; Edward N Rampersaud; P Nagesh Rao; Joseph Riss; Geoffrey Sonn; Arie S Belldegrun; Frédéric D Birkhäuser; Fairooz Kabbinavar; Allan J Pantuck
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.
Natalia Swietek; Matthias Waldert; Helene G Wiener; Maximilian Rom; Georg Schatzl; Martin Susani; Tobias Klatte
The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tobias Klatte (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michela de Martino; Andrea Haitel; Tobias Klatte; Georg Schatzl; Fritz Wrba; Matthias Waldert
High-risk human papilloma virus infection of the foreskin in asymptomatic boys.
Urology 2013;81(4):869-72.
2012: Tobias Klatte; Nils Kroeger; Joshua E Logan; Edward N Rampersaud; P Nagesh Rao; Joseph Riss; Geoffrey Sonn; Arie S Belldegrun; Frédéric D Birkhäuser; Fairooz Kabbinavar; Allan J Pantuck
Gain of chromosome 8q is associated with metastases and poor survival of patients with clear cell renal cell carcinoma.
Cancer 2012;118(23):5777-82.
2012: Natalia Swietek; Matthias Waldert; Helene G Wiener; Maximilian Rom; Georg Schatzl; Martin Susani; Tobias Klatte
The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guérin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature.
The Journal of urology 2012;188(3):748-53.
2012: Matthias Waldert; Maximilian Rom; Georg Schatzl; Natalia Swietek; Tobias Klatte
Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy.
The Journal of urology 2012;188(3):792-7.
2012: Tobias Klatte
The contemporary role of renal tumor biopsy.
European urology 2012;62(3):505-6.
2012: Maximilian Rom; Matthias Waldert; Christian Wiunig; Tobias Klatte; Armin Pycha; Andreas Reissigl; Mesut Remzi; Christian Seitz
Prospective randomized multicenter study comparing prostate cancer detection rates of end-fire and side-fire transrectal ultrasound probe configuration.
Urology 2012;80(1):15-8.
2012: Tobias Klatte; Christine Mannhalter; Georg Schatzl; Matthias Waldert; Michela de Martino; Mesut Remzi
Age-specific PCA3 score reference values for diagnosis of prostate cancer.
World journal of urology 2012;30(3):405-10.
2012: Tobias Klatte; Barbara Krammer; Michael Marberger; Mesut Remzi; Berthold Streubel; Martin Susani; Matthias Waldert; Friedrich Wrba; Michela de Martino; Andrea Haitel
Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
American journal of clinical pathology 2012;137(5):761-8.
2012: Nils Kroeger; John T Leppert; Arie S Belldegrun; Frédéric D Birkhäuser; Fairooz Kabbinavar; Tobias Klatte; Edward N Rampersaud; P Nagesh Rao; David B Seligson; Nazy Zomorodian; Allan J Pantuck
Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma.
European urology 2012;61(5):888-95.
2012: Nils Kroeger; Edward N Rampersaud; David B Seligson; Nazy Zomorodian; Arie S Belldegrun; Frédéric D Birkhäuser; Fairooz Kabbinavar; Tobias Klatte; Allan J Pantuck
Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival.
Cancer 2012;118(7):1795-802.
2012: Matthias Waldert; Tobias Klatte; Mesut Remzi; Helmut Sinzinger; Christian Kratzik
Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer?
World journal of urology 2012;30(2):233-7.
2012: M de Martino; Andrea Haitel; Konrad Hoetzenecker; Georg Alexander Roth; Matthias Waldert; Hendrik Jan Ankersmit; Tobias Klatte
Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis.
British journal of cancer 2012;106(5):904-8.
2011: Tobias Klatte; Michael Marberger
Renal cell carcinoma of native kidneys in renal transplant patients.
Current opinion in urology 2011;21(5):376-9.
2011: P Weibl; Gerd Schüller; Matthias Waldert; Bernard Geryk; Tobias Klatte; Boris Kollarik; Mesut Remzi
Interpersonal variability and present diagnostic dilemmas in Bosniak classification system.
Scandinavian journal of urology and nephrology 2011;45(4):239-44.
2011: Tobias Klatte; H Christoph Klingler; Julian Mauermann; Matthias Waldert; Peter Weibl; Gertraud Heinz-Peer; Mesut Remzi
Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
Journal of endourology / Endourological Society 2011;25(6):991-7.
2011: Matthias Waldert; Mesut Remzi; Tobias Klatte; H Christoph Klingler
FloSeal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy.
Journal of endourology / Endourological Society 2011;25(6):969-73.
2011: Michela de Martino; Tobias Klatte; Georg Schatzl; Matthias Waldert; Mesut Remzi; Andrea Haitel; Gero Kramer; Michael Marberger
Insertion/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma.
Urology 2011;77(4):1005.e9-1005.e13.
2011: Tobias Klatte; Jonathan W Said; David B Seligson; P Nagesh Rao; Michela de Martino; Brian Shuch; Nazy Zomorodian; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features.
The Journal of urology 2011;185(1):30-5.
2010: Jeffrey C La Rochelle; Tobias Klatte; Aditi Dastane; Nagesh Rao; David Seligson; Jonathan Said; Brian Shuch; Nazy Zomorodian; Fairooz Kabbinavar; Arie Belldegrun; Allan J Pantuck
Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
Cancer 2010;116(20):4696-702.
2010: Mesut Remzi; Tobias Klatte; Matthias Waldert
Words of wisdom. Re: Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Ficarra V, Novara G, Secco S, et al.
European urology 2010;58(3):462.
2010: Matthias Waldert; Sandra Waalkes; Tobias Klatte; Markus A Kuczyk; Peter Weibl; Gerd Schüller; Axel S Merseburger; Mesut Remzi
External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery.
World journal of urology 2010;28(4):531-5.
2010: Tobias Klatte; Mesut Remzi; Richard Zigeuner; Sebastian Mannweiler; Jonathan W Said; Fairooz F Kabbinavar; Andrea Haitel; Matthias Waldert; Michela de Martino; Michael Marberger; Arie S Belldegrun; Allan J Pantuck
Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
The Journal of urology 2010;184(1):53-8.
2010: Tobias Klatte; David B Seligson; Jian Yu Rao; Hong Yu; Michela de Martino; Isla Garraway; Steven G Wong; Arie S Belldegrun; Allan J Pantuck
Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome.
The Journal of urology 2010;183(6):2403-8.
2010: Tobias Klatte; Christine Anterasian; Jonathan W Said; Michela de Martino; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Fuhrman grade provides higher prognostic accuracy than nucleolar grade for papillary renal cell carcinoma.
The Journal of urology 2010;183(6):2143-7.
2010: Thomas Nelius; Tobias Klatte; Werner de Riese; Allan Haynes; Stephanie Filleur
Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy.
Medical oncology (Northwood, London, England) 2010;27(2):363-7.
2010: Matthias Waldert; Tobias Klatte; Jörg Schmidbauer; Mesut Remzi; Jakob Lackner; Michael Marberger
Color Doppler sonography reliably identifies testicular torsion in boys.
Urology 2010;75(5):1170-4.
2010: Tobias Klatte; Christian Seitz; Matthias Waldert; Michela de Martino; Zeljko Kikic; Georg A Böhmig; Andrea Haitel; Jörg Schmidbauer; Michael Marberger; Mesut Remzi
Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients.
BJU international 2010;105(9):1260-5.
2010: Matthias Waldert; Tobias Klatte; Andrea Haitel; Mehmet Ozsoy; Jörg Schmidbauer; Michael Marberger; Mesut Remzi
Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
European urology 2010;57(4):661-5.
2010: Michela De Martino; Tobias Klatte; Georg Schatzl; Mesut Remzi; Matthias Waldert; Andrea Haitel; Igor Stancik; Gero Kramer; Michael Marberger
Renal cell carcinoma Fuhrman grade and histological subtype correlate with complete polymorphic deletion of glutathione S-transferase M1 gene.
The Journal of urology 2010;183(3):878-83.
2010: Brian Shuch; Jonathan Said; Jeffrey C La Rochelle; Ying Zhou; Gang Li; Tobias Klatte; Frederic Pouliot; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
Cancer 2010;116(3):616-24.
2010: Peter Weibl; Hans-Christoph Klingler; Tobias Klatte; Mesut Remzi
Current Limitations and Perspectives in Single Port Surgery: Pros and Cons Laparo-Endoscopic Single-Site Surgery (LESS) for Renal Surgery.
Diagnostic and therapeutic endoscopy 2010;2010():759431.
2009: Tobias Klatte
Editorial comment.
The Journal of urology 2009;182(6):2606.
2009: Jörg Schmidbauer; Mesut Remzi; Tobias Klatte; Matthias Waldert; Julian Mauermann; Martin Susani; Michael Marberger
Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
European urology 2009;56(6):914-9.
2009: Brian Shuch; Jonathan Said; Jeffrey C La Rochelle; Ying Zhou; Gang Li; Tobias Klatte; Fairooz F Kabbinaavar; Allan J Pantuck; Arie S Belldegrun
Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?
The Journal of urology 2009;182(5):2164-71.
2009: Tobias Klatte
Editorial comment.
The Journal of urology 2009;182(5):2136.
2009: Michela de Martino; Tobias Klatte; David B Seligson; Jeffrey C La Rochelle; Brian Shuch; Randy Caliliw; Z Li; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.
The Journal of urology 2009;182(2):728-34.
2009: Tobias Klatte; Jonathan W Said; Michela de Martino; Jeffrey C La Rochelle; Brian Shuch; Jian Yu Rao; George V Thomas; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.
The Journal of urology 2009;181(4):1558-64; discussion 1563-4.
2009: Tobias Klatte; David B Seligson; Jian Yu Rao; Hong Yu; Michela de Martino; Kelly Kawaoka; Steven G Wong; Arie S Belldegrun; Allan J Pantuck
Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Cancer 2009;115(7):1448-58.
2009: Tobias Klatte; David B Seligson; Jeffrey C La Rochelle; Brian Shuch; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):894-900.
2009: Tobias Klatte; Michael Marberger
High-intensity focused ultrasound for the treatment of renal masses: current status and future potential.
Current opinion in urology 2009;19(2):188-91.
2009: Tobias Klatte; P Nagesh Rao; Michela de Martino; Jeffrey C La Rochelle; Brian Shuch; Nazy Zomorodian; Jonathan Said; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(5):746-53.
2008: Tobias Klatte; Allan J Pantuck
Molecular biology of renal cortical tumors.
The Urologic clinics of North America 2008;35(4):573-80; vi.
2008: Arie S Belldegrun; Tobias Klatte; Brian Shuch; Jeffrey C La Rochelle; David C Miller; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Jean B deKernion; Allan J Pantuck
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
Cancer 2008;113(9):2457-63.
2008: Tobias Klatte; Ken-Ryu Han; Jonathan W Said; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Pathobiology and prognosis of chromophobe renal cell carcinoma.
Urologic oncology 2008;26(6):604-9.
2008: Brian Shuch; Jeffrey C La Rochelle; Tobias Klatte; Stephen B Riggs; Weiqing Liu; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
Cancer 2008;113(7):1641-8.
2008: Brian Shuch; Jeffrey C La Rochelle; Jon Wu; Tobias Klatte; Stephen B Riggs; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
Cancer 2008;113(6):1324-31.
2008: Matthew B Rettig; David Heber; Jiabin An; Navindra P Seeram; Jian Y Rao; Huiren Liu; Tobias Klatte; Arie Belldegrun; Aune Moro; Susanne M Henning; Deqiong Mo; William J Aronson; Allan J Pantuck
Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism.
Molecular cancer therapeutics 2008;7(9):2662-71.
2008: Tobias Klatte; John S Lam; Brian Shuch; Arie S Belldegrun; Allan J Pantuck
Surveillance for renal cell carcinoma: why and how? When and how often?
Urologic oncology 2008;26(5):550-4.
2008: Tobias Klatte; Michela de Martino; Knut Arensmeier; Frank Reiher; Ernst P Allhoff; Detlef Klatte
Management and outcome of bilateral testicular germ cell tumors: a 25-year single center experience.
International journal of urology : official journal of the Japanese Urological Association 2008;15(9):821-6.
2008: Jean-Jacques Patard; Patricia Fergelot; Pierre I Karakiewicz; Tobias Klatte; Quoc-Dien Trinh; Nathalie Rioux-Leclercq; Jonathan W Said; Arie S Belldegrun; Allan J Pantuck
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
International journal of cancer. Journal international du cancer 2008;123(2):395-400.
2008: Allan J Pantuck; Tobias Klatte; David Seligson; Michael Atkins; Arie Belldegrun
Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3105-7; author reply 3107-9.
2008: Tobias Klatte; Arie S Belldegrun; Allan J Pantuck
The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.
BJU international 2008;101 Suppl 4():45-8.
2008: Tobias Klatte; Jean-Jacques Patard; Michela de Martino; Karim Bensalah; Gregory Verhoest; Alexandre de la Taille; Clément-Claude Abbou; Ernst Peter Allhoff; Giuseppe Carrieri; Stephen B Riggs; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
The Journal of urology 2008;179(5):1719-26.
2008: John S Lam; Tobias Klatte; Hyung L Kim; Jean-Jacques Patard; Alberto Breda; Amnon Zisman; Allan J Pantuck; Robert A Figlin
Prognostic factors and selection for clinical studies of patients with kidney cancer.
Critical reviews in oncology/hematology 2008;65(3):235-62.
2008: Tobias Klatte; Annelore Ittenson; Friedrich-Wilhelm Röhl; Martin Ecke; Ernst Peter Allhoff; Malte Böhm
Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinoma.
Onkologie 2008;31(1-2):28-34.
2008: Mehmet Ozsoy; Tobias Klatte; Matthias Waldert; Mesut Remzi
Surveillance for the management of small renal masses.
Advances in urology 2008;():196701.
2008: Tobias Klatte; David Seligson; John T Leppert; Stephen B Riggs; Hong Yu; Nazy Zomorodian; Fairooz Kabbinavar; Robert M Strieter; Arie S Belldegrun; Allan J Pantuck
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.
The Journal of urology 2008;179(1):61-6.
2008: Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur
Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.
International urology and nephrology 2008;40(1):97-104.
2007: Tobias Klatte; David Seligson; Stephen B Riggs; John T Leppert; Maria K Berkman; Mark D Kleid; Hong Yu; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7388-93.
2007: Allan J Pantuck; Jack Baniel; Ziya Kirkali; Tobias Klatte; Nazy Zomorodian; Ofer Yossepowitch; Arie S Belldegrun
A novel resectoscope for transurethral resection of bladder tumors and the prostate.
The Journal of urology 2007;178(6):2331-6; discussion 2336.
2007: Stephen B Riggs; Tobias Klatte; Arie S Belldegrun
Update on partial nephrectomy and novel techniques.
Urologic oncology 2007;25(6):520-2.
2007: Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Allan J Pantuck; Tobias Klatte; John S Lam; Francois Guille; Alexandre de la Taille; Giacomo Novara; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Denis Chautard; Eric Lechevallier; Antoine Valeri; Jean-Luc Descotes; Herve Lang; Michel Soulie; Jean-Marie Ferriere; Christian Pfister; Arnaud Mejean; Arie S Belldegrun; Jean-Jacques Patard
Unclassified renal cell carcinoma: an analysis of 85 cases.
BJU international 2007;100(4):802-8.
2007: Tobias Klatte; Allan J Pantuck; Stephen B Riggs; Mark D Kleid; Brian Shuch; Nazy Zomorodian; Fairooz Kabbinavar; Arie S Belldegrun
Prognostic factors for renal cell carcinoma with tumor thrombus extension.
The Journal of urology 2007;178(4 Pt 1):1189-95; discussion 1195.
2007: Tobias Klatte; Jonathan W Said; Arie S Belldegrun; Allan J Pantuck
Differential diagnosis of hypercalcemia in renal malignancy.
Urology 2007;70(1):179.e7-8.
2007: Tobias Klatte; Jean-Jacques Patard; Rakhee H Goel; Mark D Kleid; Francois Guille; Bernard Lobel; Claude C Abbou; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Walter Artibani; Tommaso Prayer-Galetti; Ernst Peter Allhoff; Luigi Schips; Richard Zigeuner; Robert A Figlin; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun; John S Lam
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
The Journal of urology 2007;178(1):35-40; discussion 40.
2007: Tobias Klatte; Heiko Wunderlich; Jean-Jacques Patard; Mark D Kleid; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.
BJU international 2007;100(1):21-5.
2007: Tobias Klatte; Malte Böhm; Thomas Nelius; Stephanie Filleur; Frank Reiher; Ernst Peter Allhoff
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinoma.
BJU international 2007;100(1):209-14.
2007: John S Lam; Tobias Klatte; Jean-Jacques Patard; Rakhee H Goel; François Guillè; Bernard Lobel; Claude C Abbou; Alexandre de la Taille; Jacques Tostain; Luca Cindolo; Vincenzo Altieri; Vincenzo Ficarra; Walter Artibani; Tommaso Prayer-Galetti; Luigi Schips; Richard Zigeuner; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience.
European urology 2007;52(1):155-62.
2007: Tobias Klatte; Jean-Jacques Patard; Heiko Wunderlich; Rakhee H Goel; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst Peter Allhoff; Fairooz Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.
The Journal of urology 2007;177(6):2081-6; discussion 2086-7.
2007: Allan J Pantuck; David Seligson; Tobias Klatte; Hong Yu; John T Leppert; Laurence Moore; Timothy O'Toole; Jay Gibbons; Arie S Belldegrun; Robert A Figlin
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Cancer 2007;109(11):2257-67.
2007: Tobias Klatte; Jian Yu Rao; Antoni Ribas; Allan J Pantuck
Metastatic melanoma to the kidney presenting with renal vein tumor thrombus.
Urology 2007;69(5):982.e7-9.
2007: Tobias Klatte; Jinsoo Chung; John T Leppert; John S Lam; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
BJU international 2007;99(4):821-4.
2007: Tobias Klatte; D Klatte
[Invasive bladder cancer with lymphangiosis carcinomatosa and carcinoma in situ in a 19-year-old female. Case report with 21-year follow-up].
Der Urologe. Ausg. A 2007;46(3):281-3.
2007: Tobias Klatte; Allan J Pantuck; Mark D Kleid; Arie S Belldegrun
Understanding the natural biology of kidney cancer: implications for targeted cancer therapy.
Reviews in urology 2007;9(2):47-56.
2006: Tobias Klatte; Annelore Ittenson; Friedrich-Wilhelm Röhl; M Ecke; Ernst Peter Allhoff; M Böhm
Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial.
British journal of cancer 2006;95(9):1167-73.
2006: Tobias Klatte; D Klatte
[History and personalities at the Department of Urology, University of Magdeburg. From medical academy to university].
Der Urologe. Ausg. A 2006;45(10):1318-21.
2006: Tobias Klatte; D Klatte; M Böhm; Ernst Peter Allhoff
[Radionuclide bone scan in patients with newly diagnosed prostate cancer. Clinical aspects and cost analysis].
Der Urologe. Ausg. A 2006;45(10):1293-4, 1296-9.
2006: Thomas Nelius; Tobias Klatte; Ron Yap; Thomas Kalinski; Albrecht Röpke; Stephanie Filleur; Ernst Peter Allhoff
A randomized study of docetaxel and dexamethasone with low- or high-dose estramustine for patients with advanced hormone-refractory prostate cancer.
BJU international 2006;98(3):580-5.
2005: Thomas Nelius; Frank Reiher; Tobias Lindenmeir; Tobias Klatte; Olrik Rau; Jens Burandt; Stephanie Filleur; Ernst Peter Allhoff
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancer.
Onkologie 2005;28(11):573-8.
2003: M Böhm; Tobias Klatte; Ernst Peter Allhoff
[Perioperative immune modulation in renal cell carcinoma--review of the current situation].
Aktuelle Urologie 2003;34(5):319-27.
2003: M Böhm; Annelore Ittenson; Tobias Klatte; K F Schierbaum; Friedrich-Wilhelm Röhl; Siegfried Ansorge; Ernst Peter Allhoff
Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
Folia biologica 2003;49(2):63-8.